Alliance is constantly considering a number of in-licensing opportunities. At this stage we will look at possibilities in all therapy areas, but we have a particular interest in expanding our dermatology franchise.

If you are seeking a UK and European market entry partner, Alliance's sales, marketing and regulatory expertise can help you navigate the whole process from marketing authorisation submission to field force deployment.

Alliance will expand infrastructure to fit the opportunity.

Click here to contact the business development team for an immediate product opportunity appraisal.

Alliance has two key development products and is at the stage where it wishes to discuss partnership opportunities for their development and marketing across Europe:

Isprelor - 25mcg misoprostol with applicator device indicated for the treatment of induction of labour.  Please click here for further information on Isprelor.

Posidorm - a novel 1.5mg surge-sustained formulation of melatonin indicated for the treatment of sleep disorders.  Please click here for further information on Posidorm.

Click here to contact Alliance business development to discuss licensing partnership opportunities with Isprelor or Posidorm.